EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications

Jirapat Wonglhow iD, Jarukit Tantipisit, Panu Wetwittayakhlang iD, Patrapim Sunpaweravong iD, Chirawadee Sathitruangsak iD, Kanet Kanjanapradit iD, Phatcharaporn Thongwatchara, Arunee Dechaphunkul iD

Cancers · 29.04.2025 · 17 (9) · 1492

DOI: 10.3390/cancers17091492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.04.2025. Verfasst von Jirapat Wonglhow und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epstein–Barr virus-associated gastric cancer (EBVaGC) represents a distinct molecular subgroup with potential responsiveness to immunotherapy approved for programmed death-ligand 1 (PD-L1)-positive gastric cancer. This retrospective study aimed to assess the prevalence and association between EBVaGC and PD-L1 positivity among patients with gastric adenocarcinoma treated at a university hospital in Southern Thailand from January 2017 to October 2023.

Methods

The EBV status of the patients and PD-L1 expression were determined using in situ hybridization and immunohistochemistry, respectively.

Results

The prevalence of EBVaGC was 4.5% among 132 patients, whereas 9.1% of patients exhibited a PD-L1 combined positive score (CPS) of ≥1, with no significant association observed between them. EBVaGC was more prevalent in males, non-antral tumors, diffuse/mixed histologic subtypes, and poorly differentiated tumors. Median overall survival for patients with EBVaGC and PD-L1 CPS ≥ 1 was 9.48 and 14.19 months, respectively, compared with 10.32 and 9.79 months for those with non-EBVaGC (hazard ratio: 1.24; 95% CI: 0.50–3.04; p = 0.645) and PD-L1 CPS < 1 (hazard ratio: 0.82; 95% CI: 0.40–1.69; p = 0.590), respectively.

Conclusions

Our findings revealed a low prevalence of EBVaGC and PD-L1 positivity in Thailand, with no significant association or survival impact observed. These findings highlight the regional variation in these biomarkers and support EBV as an independent biomarker from PD-L1. However, further research, particularly studies evaluating immunotherapy outcomes, is warranted to clarify the predictive and clinical significance of EBV in gastric cancer.

Schlagwörter

Stichwörter der Autor:innen

Epstein–Barr virusPD-L1 expressionbiomarkergastric cancerprognosissurvival outcome

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Department of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.

ORCID-Profile: Jirapat Wonglhow, Panu Wetwittayakhlang, Patrapim Sunpaweravong, Chirawadee Sathitruangsak, Kanet Kanjanapradit, Arunee Dechaphunkul

Förderung

  • Faculty of Medicine, Prince of Songkla University

Zitieren

APA

Wonglhow, J., Tantipisit, J., Wetwittayakhlang, P., Sunpaweravong, P., Sathitruangsak, C., Kanjanapradit, K., Thongwatchara, P., & Dechaphunkul, A. (2025). Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications. Cancers, 17(9), 1492. https://doi.org/10.3390/cancers17091492

Vancouver

Wonglhow J, Tantipisit J, Wetwittayakhlang P, Sunpaweravong P, Sathitruangsak C, Kanjanapradit K, et al. Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications. Cancers. 2025;17(9):1492. doi:10.3390/cancers17091492

BibTeX
@article{Wonglhow2025,
  author = {Wonglhow, Jirapat and Tantipisit, Jarukit and Wetwittayakhlang, Panu and Sunpaweravong, Patrapim and Sathitruangsak, Chirawadee and Kanjanapradit, Kanet and Thongwatchara, Phatcharaporn and Dechaphunkul, Arunee},
  title = {Association Between Epstein–Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1492},
  doi = {10.3390/cancers17091492}
}
Kostenlos starten →